Researchers sought to identify the psychosocial challenges patients with prostate cancer face as they navigate their journey through survivorship.

Access to and use of palliative care are similar between sexes and genders; but qualitative data suggest patients’ experiences with these services differ by sex and gender.

Patients with cancer more likely than those with other illnesses to report receiving discordant life-extended care.

Resection beyond contrast-enhancing tumor margins is associated with superior outcomes in patients with primary glioblastoma, a study suggests.

The safety profile of the investigational regimen was manageable, with low-grade cytokine release syndrome and no treatment-related discontinuations.

An estimated 3 out of 10 people using cannabis have a cannabis-related disorder, which suggests many are at risk for any adverse health effects.

There were no cases of HER2 positivity among patients with gliomas, sarcomas, small cell lung cancer, gastrointestinal stromal tumors, thyroid carcinoma, uterine sarcoma, thymic carcinoma, and Merkel ...

Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers.

The R2-MTX and POR/ROM regimens achieved higher response rates than R-MTX but showed no statistical advantage in overall survival.

Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib.

Models estimated patient’s lifetime risk of dying from nonmetastatic prostate cancer rather than other causes.

43.2 percent missed opportunity rate reported for germline genetic testing, risk-reducing surgery in those with affected first-degree relative.